Postpartum vascular dysfunction in the reduced uteroplacental perfusion model of preeclampsia

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Brennan, Lesley ^a,b   Morton, Jude S ^a,b   Quon, Anita ^a,b   Davidge, Sandra T ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b The Women's and Children's Health Research Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; METHYLCHOLINE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENDOTHELIAL DYSFUNCTION; FEMALE; GESTATIONAL AGE; MATERNAL HYPERTENSION; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; PATHOGENESIS; PERFUSION PRESSURE; PHENOTYPE; PREECLAMPSIA; PROTEIN EXPRESSION; RAT; REDUCED UTEROPLACENTAL PERFUSION PRESSURE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION;

EID: 84992154251     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0162487     Document Type: Article

References (51)

1. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstetrics & Gynecology. 2003;102(1):181-92. http://dx.doi.org/10.1016/S0029-7844 (03) 00475-7.
2. Duley L. The global Impact of pre-eclampsia and eclampsia. Seminars in Perinatology. 2009;33(3):130-7. http://dx.doi.org/10.1053/j.semperi.2009.02.010. doi: 10.1053/j.semperi.2009.02.010 PMID: 19464502
3. Gilbert JS, Ryan MJ, La Marca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2008;294(2):H541-H50. doi: 10.1152/ajpheart.01113.2007 PMID: 18055511
4. Brennan LJ, Morton JS, Davidge ST. Vascular dysfunction in preeclampsia. Microcirculation. 2014;21(1):4-14. doi: 10.1111/micc.12079 PMID: 23890192
5. Gongora M, Wenger N. Cardiovascular Complications of Pregnancy. International Journal of Molecular Sciences. 2015;16(10):23905. Available: http://www.mdpi.com/1422-0067/16/10/23905. doi: 10. 3390/ijms161023905 PMID: 26473833
6. Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. European Journal of Epidemiology. 2013;28(1):1-19. doi: 10.1007/s10654-013-9762-6 PMID: 23397514
7. Paauw Nina D, Luijken K, Franx A, Verhaar Marianne C, Lely AT. Long-term renal and cardiovascular risk after preeclampsia: towards screening and prevention. Clinical Science. 2016;130(4):239-46. doi: 10.1042/cs20150567 PMID: 26769659
8. Bellamy L, Casas J-P, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. British Medical Journal. 2007;335(7627):974. PMID: 17975258
9. Behrens I, Basit S, Lykke J, Ranthe MF, Wohlfahrt J, Bundgaard H, et al. Association between hypertensive disorders of pregnancy and later risk of cardiomyopathy. JAMA. 2016;315(10):1026-33. doi: 10.1001/jama.2016.1869 PMID: 26954411
10. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analyses. Am Heart J. 2008;156(5):918-30. http://dx. doi.org/10.1016/j.ahj.2008.06.042. doi: 10.1016/j.ahj.2008.06.042 PMID: 19061708
11. Newstead J, von Dadelszen P, Magee LA. Preeclampsia and future cardiovascular risk. Expert review of cardiovascular therapy. 2007;5(2):283-94. doi: 10.1586/14779072.5.2.283 PMID: 17338672
12. Myatt L, Roberts JM. Preeclampsia: Syndrome or Disease? Current Hypertension Reports. 2015;17(11):1-8. doi: 10.1007/s11906-015-0595-4
13. Blaauw J, Graaff R, van Pampus MG, van Doormaal JJ, Smit AJ, Rakhorst G, et al. Abnormal endothelium-dependent microvascular reactivity in recently preeclamptic women. Obstetrics & Gynecology. 2005;105(3):626-32. Epub 2005/03/02. doi: 10.1097/01. AOG.0000153490.41973.e0 PMID: 15738035.
14. Chambers JC, Fusi L, Malik IS, Haskard DO, De Swiet M, Kooner JS. ASsociation of maternal endothelial dysfunction with preeclampsia. JAMA. 2001;285(12):1607-12. doi: 10.1001/jama.285.12.1607 PMID: 11268269
15. Weissgerber TL, Milic NM, Milin-Lazovic JS, Garovic VD. Impaired Flow-Mediated Dilation Before, During, and After Preeclampsia: A Systematic Review and Meta-Analysis. Hypertension. 2016;67(2):415-23. doi: 10.1161/hypertensionaha.115.06554 PMID: 26711737
16. Aykas F, Solak Y, Erden A, Bulut K, Dogan S, Sarli B, et al. Persistence of Cardiovascular Risk Factors in Women With Previous Preeclampsia: A Long-term Follow-up Study. Journal of Investigative Medicine. 2015;63(4):641-5. doi: 10.1097/jim.0000000000000189 PMID: 25738648
17. Henriques A C PT Carvalho FHC, Feitosa HN Macena RHM, Mota R M S Alencar JCG. Endothelial dysfunction after pregnancy-induced hypertension. Int J Gyn Ob. 2014;124(3):230-4. http://dx.doi.org/10.1016/j.ijgo.2013.08.016.
18. Ramsay JE, Stewart F, Greer IA, Sattar N. Microvascular dysfunction: a link between pre-eclampsia and maternal coronary heart disease. BJOG: An International Journal of Obstetrics & Gynaecology. 2003;110(11):1029-31. doi: 10.1111/j.1471-0528.2003.02069.x
19. Souwer ETD, Blaauw J, Coffeng SM, Smit AJ, Van Doormaal JJ, Faas MM, et al. Decreased arterial elasticity in formerly early-onset preeclamptic women. Acta obstetricia et gynecologica Scandinavica. 2011;90(7):797-801. doi: 10.1111/j.1600-0412.2011.01128.x PMID: 21418159
20. Estensen M-E, Remme EW, Grindheim G, Smiseth OA, Segers P, Henriksen T, et al. Increased Arterial Stiffness in Pre-eclamptic Pregnancy at Term and Early and Late Postpartum: A Combined Echocardiographic and Tonometric Study. American journal of hypertension. 2013;26(4):549-56. doi: 10. 1093/ajh/hps067 PMID: 23467210
21. Lampinen KH, Ronnback M, Groop PH, Nicholls MG, Yandle TG, Kaaja RJ. Increased plasma norepinephrine levels in previously pre-eclamptic women. Journal of Human Hypertension. 2014;28(4):269-73. Epub 2013/09/21. doi: 10.1038/jhh.2013.84 PMID: 24048293.
22. der Graaf van AM, der Wiel van MK, Frenay AS, Goor van H, Klok P, Henning R, et al. OS056. Angiotensin II sensitivity and endothelial dysfunction afterexperimental preeclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health. 2012;2(3):207. http://dx.doi.org/10. 1016/j.preghy.2012.04.057.
23. Bytautiene E, Lu F, Tamayo EH, Hankins GDV, Longo M, Kublickiene K, et al. Long-term maternal cardiovascular function in a mouse model of sFlt-1-induced preeclampsia. Am J Physiol Heart Circ Physiol. 2010;298(1):H189-H93. doi: 10.1152/ajpheart.00792.2009 PMID: 19915174
24. Pruthi D, Khankin EV, Blanton RM, Aronovitz M, Burke SD, McCurley A, et al. Exposure to Experimental Preeclampsia in Mice Enhances the Vascular Response to Future Injury. Hypertension. 2015;65(4):863-70. doi: 10.1161/hypertensionaha.114.04971 PMID: 25712723
25. Li J, La Marca B, Reckelhoff JF. A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. Am J Physiol Heart Circ Physiol. 2012;303(1):H1-H8. doi: 10.1152/ajpheart. 00117.2012 PMID: 22523250
26. Morton JS, Abdalvand A, Jiang Y, Sawamura T, Uwiera RRE, Davidge ST. Lectin-like oxidized lowdensity lipoprotein 1 receptor in a reduced uteroplacental perfusion pressure rat model of preeclampsia. Hypertension. 2012;59(5):1014-20. doi: 10.1161/hypertensionaha.112.191825 PMID: 22392901
27. Morton JS, Quon A, Cheung PY, Sawamura T, Davidge ST. Effect of sodium tanshinone IIA sulfonate treatment in a rat model of preeclampsia. American Journal of Physiology Regulatory, Integrative and Comparative Physiology. 2015;308(3):R163-72. Epub 2014/12/06. doi: 10.1152/ajpregu.00222.2014 PMID: 25477421.
28. Sankaralingam S, Xu Y, Sawamura T, Davidge ST. Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: role for peroxynitrite. Hypertension. 2009;53(2):270-7. doi: 10.1161/hypertensionaha.108.122630 PMID: 19104003
29. Sankaralingam S, Xu Y, Sawamura T, Davidge ST. Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: role for peroxynitrite. Hypertension. 2009;53(2):270-7. Epub 2008/12/24. doi: 10.1161/HYPERTENSIONAHA.108. 122630 PMID: 19104003.
30. Abdalvand A, Morton JS, Bourque SL, Quon AL, Davidge ST. Matrix metalloproteinase enhances bigendothelin-1 constriction in mesenteric vessels of pregnant rats with reduced uterine blood flow. Hypertension. 2013;61(2):488-93. Epub 2013/01/09. doi: 10.1161/HYPERTENSIONAHA.111.00055 PMID: 23297376.
31. Sengupta P. The laboratory rat: relating its age with human's. International Journal of Preventive Medicine. 2013;4(6):624. PMID: 23930179
32. Morton JS, Abdalvand A, Jiang Y, Sawamura T, Uwiera RR, Davidge ST. Lectin-like oxidized low-density lipoprotein 1 receptor in a reduced uteroplacental perfusion pressure rat model of preeclampsia. Hypertension. 2012;59(5):1014-20. Epub 2012/03/07. doi: 10.1161/HYPERTENSIONAHA.112. 191825 PMID: 22392901.
33. Morton JS, Quon A, Cheung PY, Sawamura T, Davidge ST. Effect of sodium tanshinone IIA sulfonate treatment in a rat model of preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2015;308(3):R163-72. Epub 2014/12/06. doi: 10.1152/ajpregu.00222.2014 PMID: 25477421.
34. Greenway CV. Role of splanchnic venous system in overall cardiovascular homeostasis. Federation proceedings. 1983;42(6):1678-84. Epub 1983/04/01. PMID: 6832386.
35. Rothe CF. Reflex control of veins and vascular capacitance. Physiological reviews. 1983;63(4):1281-342. Epub 1983/10/01. PMID: 6361810.
36. Hag AMF, Kristoffersen US, Pedersen SF, Gutte H, Lebech A-M, Kjaer A. Regional Gene Expression of LOX-1, VCAM-1, and ICAM-1 in Aorta of HIV-1 Transgenic Rats. PloS one. 2009;4(12):e8170. doi: 10.1371/journal.pone.0008170 PMID: 19997643
37. Chen X, Zhang H, McAfee S, Zhang C. The reciprocal relationship between adiponectin and LOX-1 in the regulation of endothelial dysfunction in ApoE knockout mice. Am J Physiol Heart Circ Physiol. 2010;299(3):H605-H12. doi: 10.1152/ajpheart.01096.2009 PMID: 20581092
38. Wang L-j, Yu Y-h, Zhang L-g, Wang Y, Niu N, Li Q, et al. Taurine rescues vascular endothelial dysfunction in streptozocin-induced diabetic rats: Correlated with downregulation of LOX-1 and ICAM-1 expression on aortas. European journal of pharmacology. 2008;597 1-3): 75-80. doi: 10.1016/j. ejphar.2008.08.031 PMID: 18796303
39. Nagase M, Hirose S, Sawamura T, Masaki T, Fujita T. Enhanced Expression of Endothelial Oxidized Low-Density Lipoprotein Receptor (LOX-1) in Hypertensive Rats. Biochemical and Biophysical Research Communications. 1997;237(3):496-8. http://dx.doi.org/10.1006/bbrc.1997.7176. PMID: 9299391
40. Andersson IJ, Sankaralingam S, Davidge ST. Restraint stress up-regulates lectin-like oxidized lowdensity lipoprotein receptor-1 in aorta of apolipoprotein E-deficient mice. Stress. 2010;13(5):454-60. doi: 10.3109/10253891003758901 PMID: 20666645
41. Lee Y-C, Chang H-H, Chiang C-L, Liu C-H, Yeh J-I, Chen M-F, et al. Role of Perivascular Adipose Tissue-Derived Methyl Palmitate in Vascular Tone Regulation and Pathogenesis of Hypertension. Circulation. 2011;124(10):1160-71. doi: 10.1161/circulationaha.111.027375 PMID: 21844078
42. Murias JM, Campos OA, Hall KE, McDonald MW, Melling CJ, Noble EG. Vessel-specific rate of vasorelaxation is slower in diabetic rats. Diab Vasc Dis Res. 2013;10(2):179-86. doi: 10.1177/1479164112454758 PMID: 22947492
43. Murias JM, Grise KN, Jiang M, Kowalchuk H, Melling CWJ, Noble EG. Acute endurance exercise induces changes in vasorelaxation responses that are vessel-specific. Am J Physiol Regul Integr Comp Physiol. 2013;304(7):R574-R80. doi: 10.1152/ajpregu.00508.2012 PMID: 23408026
44. Raveaud S, Mezin P, Lavanchy N, Starcher B, Mecham RP, Verdetti J, et al. Effects of chronic treatment with a low dose of nicorandil on the function of the rat aorta during ageing. Clinical and Experimental Pharmacology and Physiology. 2009;36(10):988-94. doi: 10.1111/j.1440-1681.2009.05174.x PMID: 19473347
45. Erlandsson L, Nääv Å, Hennessy A, Vaiman D, Gram M, Åkerstrom B, et al. Inventory of novel animal models addressing etiology of preeclampsia in the development of new therapeutic/intervention opportunities. Am J Reprod Immunol. 2015;75(3):402-10. doi: 10.1111/aji.12460 PMID: 26685057
46. Lambert G, Brichant JF, Hartstein G, Bonhomme V, Dewandre PY. Preeclampsia: an update. Acta anaesthesiologica Belgica. 2014;65(4):137-49. Epub 2015/01/28. PMID: 25622379.
47. Simaan M, Cadorette C, Poterek M, St-Louis J, Brochu M. Calcium channels contribute to the decrease in blood pressure of pregnant rats. Am J Physiol Heart Circ Physiol. 2002;282(2):H665-H71. doi: 10.1152/ajpheart.01183.2000 PMID: 11788416
48. Podymow T, August P. Postpartum Course of Gestational Hypertension and Preeclampsia. Hypertension in Pregnancy. 2010;29(3):294-300. doi: 10.3109/10641950902777747 PMID: 20670153
49. Sankaralingam S, Xu H, Jiang Y, Sawamura T, Davidge ST. Evidence for increased methylglyoxal in the vasculature of women with preeclampsia: role in upregulation of LOX-1 and arginase. Hypertension. 2009;54(4):897-904. Epub 2009/08/19. doi: 10.1161/HYPERTENSIONAHA.109.135228 PMID: 19687346.
50. Qiu C, Phung T, Vadachkoria S, Muy-Rivera M, Sanchez S, Williams M. Oxidized low-density lipoprotein (Oxidized LDL) and the risk of preeclampsia. Physiological research. 2006;55(5):491. PMID: 16343047
51. Wakatsuki A, Ikenoue N, Okatani Y, Shinohara K, Fukaya T. Lipoprotein particles in preeclampsia: susceptibility to oxidative modification. Obstetrics & Gynecology. 2000;96(1):55-9.